Search
Descriptor English: 2019-nCoV Vaccine mRNA-1273
Descriptor Spanish: Vacuna nCoV-2019 mRNA-1273
Descriptor vacuna de ARNm-1273 contra el SARS-CoV-2
Entry term(s) ARNm-1273
ARNm-1273.211
CX-024414
M-1273
Spikevax
TAK-919
elasomerán
mRNA-1273.211
vacuna bivalente contra la COVID-19 de Moderna
vacuna contra la COVID-19 de Moderna
vacuna de ARN contra la COVID-19 de Moderna
vacuna de ARN frente a la COVID-19 de Moderna
vacuna frente a la COVID-19 de Moderna
Scope note: Vacuna de ARNm contra el SARS-CoV-2 desarrollada por Moderna.
Descriptor Portuguese: Vacina de mRNA-1273 contra 2019-nCoV
Descriptor French: Vaccin ARNm-1273 contre la COVID-19
Entry term(s): 2019 nCoV Vaccine mRNA 1273
CX 024414
CX-024414
CX024414
Elasomeran
M 1273
M-1273
M1273
Moderna COVID 19 Vaccine, Bivalent
Moderna COVID-19 Vaccine
Moderna COVID-19 Vaccine RNA
Moderna COVID-19 Vaccine, Bivalent
Spikevax
TAK-919
mRNA 1273
mRNA 1273.211
mRNA-1273
mRNA-1273, 2019-nCoV Vaccine
mRNA-1273.211
Tree number(s): D12.776.828.868.228.500.500
D20.215.894.865.450.500.500
D20.215.894.899.085.250
D23.050.865.450.500.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000090983
Scope note: mRNA vaccine against SARS-CoV-2 developed by Moderna.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Registry Number: EPK39PL4R4
Public MeSH Note: 2022; 2019-NCOV VACCINE MRNA-1273 was indexed under COVID-19 VACCINES 2021
History Note: 2022(2021)
DeCS ID: 59829
Unique ID: D000090983
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2022/01/01
Date of Entry: 2021/07/09
Revision Date: 2023/05/22
2019-nCoV Vaccine mRNA-1273 - Preferred
Concept UI M000747630
Scope note mRNA vaccine against SARS-CoV-2 developed by Moderna.
Preferred term 2019-nCoV Vaccine mRNA-1273
Entry term(s) 2019 nCoV Vaccine mRNA 1273
Moderna COVID-19 Vaccine
Moderna COVID-19 Vaccine RNA
mRNA 1273
mRNA-1273
mRNA-1273, 2019-nCoV Vaccine
TAK-919 - Related but not broader or narrower
Concept UI M000753670
Preferred term TAK-919
mRNA-1273.211 - Narrower
Concept UI M000753669
Preferred term mRNA-1273.211
Entry term(s) mRNA 1273.211
Spikevax - Narrower
Concept UI M000754130
Preferred term Spikevax
M-1273 - Narrower
Concept UI M000757296
Preferred term M-1273
Entry term(s) M 1273
M1273
CX-024414 - Narrower
Concept UI M000757647
Preferred term CX-024414
Entry term(s) CX 024414
CX024414
Elasomeran - Related but not broader or narrower
Concept UI M000757965
Preferred term Elasomeran
Moderna COVID-19 Vaccine, Bivalent - Narrower
Concept UI M000759674
Preferred term Moderna COVID-19 Vaccine, Bivalent
Entry term(s) Moderna COVID 19 Vaccine, Bivalent



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey